Researchers have discovered a potential new pharmaceutical candidate for tuberculosis, finding that the antimicrobial peptide NZX rapidly and effectively kills TB bacteria. [ + ]

Researchers have created a fact-checking program that is tackling the problem of incorrectly published biomedical research results, whether intentional or otherwise. [ + ]

Scientists have developed a nutrient-rich liquid that enables collected horse semen to live for two weeks outside the body without the need to be frozen. [ + ]

Sartorius Stedim Biotech and Novasep have entered into a collaboration agreement in the area of chromatography and single-use bioprocessing. [ + ]

The influenza vaccine may be less effective in the elderly because their B cells are less capable of producing antibodies that can adapt to protect against new viral strains. [ + ]

Scientists have successfully activated molecules located inside cell tissues using two-photon excitation from infrared light lasers, with an efficiency of almost 100%. [ + ]

The directors of Don Whitley Scientific are sad to announce that the company's founder and chairman, Dr Don Whitley, has died at age 89 after a short illness. [ + ]

A new international research laboratory, which aims to turbocharge scientific collaboration between Australia and France, is set to be established in Adelaide. [ + ]

A robotic rover deployed in the most Mars-like environment on Earth, Chile's Atacama Desert, has recovered subsurface soil samples during a trial mission to find signs of life. [ + ]

A boy and a girl in Brisbane have been confirmed as the second set of semi-identical twins in the world — and the first to be identified by doctors during pregnancy. [ + ]

A new map of the brain's immune system reveals that the phagocytes in the brain — the so-called microglia — all have the same core signature but adapt in different ways depending on their function. [ + ]

The board of medicinal cannabis company AusCann has announced the appointment of Ido Kanyon as Chief Executive Officer, commencing 22 May. [ + ]

Trial data showed that Melbourne biotech company Aravax's therapy has a highly favourable safety profile, even in patients with severe peanut allergies. [ + ]

Thermo Fisher Scientific has signed a multiyear agreement with German immunotherapy company BioNTech, focused on supplying critical raw materials for the manufacturing of precise immunotherapy vaccine candidates. [ + ]

Direct-acting antivirals have been found to be associated with a reduced risk of liver cancer and death in people with chronic hepatitis C. [ + ]